Inter Pharma PCL (BKK:IP)
Thailand · Delayed Price · Currency is THB 5.50
-0.05 (-0.90%)
Aug 11, 2026, 10:16 AM ICT
Inter Pharma PCL Financials Overview
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2,242 | 2,214 | 1,912 | 1,799 | 1,534 | 920.98 |
Revenue Growth | 14.52% | 15.80% | 6.29% | 17.23% | 66.61% | 106.07% |
Gross Profit Gross Profit Growth | 948.58 | 920.76 | 724.36 | 676.98 | 629.03 | 413.14 |
Operating Income Operating Income Growth | 207.49 | 191.97 | 74.22 | 109.4 | 170.8 | 145.77 |
Net Income Net Income Growth | 132.64 | 122.38 | 36.65 | 50.79 | 118.88 | 105.22 |
Earnings Per Share EPS Growth | 0.22 | 0.20 | 0.06 | 0.08 | 0.22 | 0.22 |
EPS Growth | 185.96% | 233.93% | -27.84% | -62.45% | 0.91% | 98.19% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Human Healthcare Human Healthcare Growth | 1,587 | 1,578 | 1,354 | 1,204 | 1,136 | 572.42 |
Animal Healthcare Animal Healthcare Growth | 387.89 | 373.48 | 346.38 | 352.06 | 358 | 336.21 |
Hospital and clinics Hospital and clinics Growth | 247.63 | 241.99 | 197.29 | 224.84 | 29.22 | - |
Unallocated Other Income Unallocated Other Income Growth | 19.86 | 20.57 | 14.62 | 17.54 | 11.12 | 12.35 |
Total Total Growth | 2,242 | 2,214 | 1,912 | 1,799 | 1,534 | 920.99 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 305.01 | 281.65 | 185.53 | 413.25 | 777.25 | 174.67 |
Total Debt Total Debt Growth | 377.01 | 400.94 | 394.45 | 399.95 | 539 | 356.17 |
Net Cash (Debt) Net Cash Growth | -72 | -119.29 | -208.92 | 13.3 | 238.25 | -181.5 |
Net Cash Growth | - | - | - | -94.42% | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.12 | -0.20 | -0.35 | 0.02 | 0.45 | -0.38 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 277.25 | 307.88 | 177.84 | 121.42 | 143.09 | -41.57 |
Capital Expenditures CapEx Growth | -144.28 | -140.56 | -237.43 | -106.46 | -27.37 | -224.15 |
Free Cash Flow Free Cash Flow Growth | 132.97 | 167.33 | -59.59 | 14.96 | 115.72 | -265.73 |
Free Cash Flow Growth | - | - | - | -87.07% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 42.30% | 41.59% | 37.89% | 37.64% | 40.99% | 44.86% |
Operating Margin | 9.25% | 8.67% | 3.88% | 6.08% | 11.13% | 15.83% |
Pretax Margin | 8.37% | 7.73% | 2.76% | 4.52% | 9.56% | 14.95% |
Profit Margin | 5.92% | 5.53% | 1.92% | 2.82% | 7.75% | 11.42% |
FCF Margin | 5.93% | 7.56% | -3.12% | 0.83% | 7.54% | -28.85% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.073 | 0.073 | - | 0.021 | 0.111 |
Dividend Per Share Growth | 0% | - | - | -80.69% | - |
Dividend Yield | 1.32% | 1.62% | - | 0.40% | 1.26% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 25.33 | 22.75 | 53.19 | 66.01 | 46.38 | 55.23 |
Forward PE | - | 22.57 | 22.57 | 20.28 | 27.79 | 41.49 |
P/FCF Ratio | 25.27 | 16.64 | - | 224.13 | 47.64 | - |
PS Ratio | 1.50 | 1.26 | 1.02 | 1.86 | 3.59 | 6.31 |